JSR Life Sciences today announced that KBI Biopharma Inc. KBI and Selexis SA are consolidating as one organization under the KBI Biopharma name to accelerate innovation and growth for its global biopharma customers.
Life sciences veteran executive J.D. Mowery is the new chief executive officer at KBI Biopharma and Selexis SA. He succeeds Tim Lowery who was named CEO on an interim basis last November.
St. Louis County leaders are urging residents to report property damage caused by flash floods this week by calling 211, the United Way’s hotline to track damage. County leaders say reporting the damage will help the Federal Emergency Management Agency determine how to provide resources.